Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578682 · ClinicalTrials.gov registry record · Phase 1
A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
NCT00578682 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 31 participants.
The verdict
NCT00578682, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
To evaluate the safety and tolerability of a single IV dose of MEDI-557.
Interventions
- BIOLOGICAL MEDI-557
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00578682
The ClinicalTrials.gov registry entry for NCT00578682 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDI-557 is the first listed.
NCT00578682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00578682 about?
NCT00578682 is a clinical study titled "A Phase I, Randomized, Double-Blind, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-557". To evaluate the safety and tolerability of a single IV dose of MEDI-557.
What is the current status of trial NCT00578682?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2007-12. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00578682?
The interventions under investigation include: MEDI-557 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00578682?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.